Advent Bioservices has taken a 10-year lease of lab and office space at Unity Campus, Cambridge.
The firm has taken space in the Cadence building, which reached practical completion last May and is now 87 per cent let.
The letting to Advent Bioservices, a cell therapy contract development and manufacturing organisation, means just 10,825 sq ft remains available in the building.
Katherine Friend, director – investment and asset management, Howard Group, said: “We are thrilled to welcome Advent Bioservices to Unity Campus. Their groundbreaking work in cell therapy aligns perfectly with our vision for Unity Campus as a hub for world-class innovation, breakthroughs, and collaboration in the life sciences sector and further reinforces Unity Campus’ position as a prime destination for pioneering research and development. We look forward to supporting their growth and success within our community.”
Mike Scott, president of Advent Bioservices, said: “We are delighted to be taking occupancy on Unity Campus. This space will permit Advent to expand and diversify process development, microbiological testing and quality assurance and quality control services to Biotech and drug development companies working in the cell and gene therapy sector.”
© Eastern Echo (powered by ukpropertyforums.com).
Sign up to receive our weekly free journal, The Forum here.
